Wang Ronghua 4
4 · Biostar Pharmaceuticals, Inc. · Filed Jun 6, 2011
Insider Transaction Report
Form 4
Wang Ronghua
DirectorChairman, CEO10% Owner
Transactions
- Purchase
Common Stock
2011-06-03$1.27/sh+6,900$8,763→ 8,996,473 total
Footnotes (1)
- [F1]Purchase made pursuant to the stock repurchase plan of the Reporting Person as previously approved by the Board of Directors.